Objective:To study the effect of adjuvant ozone autohemotherapy combined with naloxone therapy on respiratory function and neurological function in COPD patients with pulmonary encephalopathy.Methods: A total of 30 CO...Objective:To study the effect of adjuvant ozone autohemotherapy combined with naloxone therapy on respiratory function and neurological function in COPD patients with pulmonary encephalopathy.Methods: A total of 30 COPD patients with pulmonary encephalopathy who were treated in our hospital between May 2013 and January 2016 were collected and divided into the control group and observation group (n=15) according to the random number table. Control group of patients received conventional treatment + naloxone therapy, observation group of patients received conventional treatment + ozone autohemotherapy combined with naloxone therapy, and the therapies lasted for 10 d. Differences in the levels of arterial blood gas indexes, peripheral blood nerve injury indexes and cerebrospinal fluid nerve autophagy indexes were compared between two groups of patients before and after treatment.Results:Before treatment, differences in the levels of arterial blood gas indexes, peripheral blood nerve injury indexes and cerebrospinal fluid nerve autophagy indexes were not statistically significant between two groups of patients. After treatment, the arterial blood gas pH value and PaO2 level of observation group were higher than those of control group while PaCO2 level was lower than that of control group;peripheral blood nerve injury indexes S100β, NSE and MBP contents were lower than those of control group;cerebrospinal fluid neural apoptosis indexesβ-GBA and Atg7 contents were lower than those of control group.Conclusion: Adjuvant ozone autohemotherapy combined with naloxone therapy can optimize the respiratory function and reduce the nerve injury in COPD patients with pulmonary encephalopathy.展开更多
文摘Objective:To study the effect of adjuvant ozone autohemotherapy combined with naloxone therapy on respiratory function and neurological function in COPD patients with pulmonary encephalopathy.Methods: A total of 30 COPD patients with pulmonary encephalopathy who were treated in our hospital between May 2013 and January 2016 were collected and divided into the control group and observation group (n=15) according to the random number table. Control group of patients received conventional treatment + naloxone therapy, observation group of patients received conventional treatment + ozone autohemotherapy combined with naloxone therapy, and the therapies lasted for 10 d. Differences in the levels of arterial blood gas indexes, peripheral blood nerve injury indexes and cerebrospinal fluid nerve autophagy indexes were compared between two groups of patients before and after treatment.Results:Before treatment, differences in the levels of arterial blood gas indexes, peripheral blood nerve injury indexes and cerebrospinal fluid nerve autophagy indexes were not statistically significant between two groups of patients. After treatment, the arterial blood gas pH value and PaO2 level of observation group were higher than those of control group while PaCO2 level was lower than that of control group;peripheral blood nerve injury indexes S100β, NSE and MBP contents were lower than those of control group;cerebrospinal fluid neural apoptosis indexesβ-GBA and Atg7 contents were lower than those of control group.Conclusion: Adjuvant ozone autohemotherapy combined with naloxone therapy can optimize the respiratory function and reduce the nerve injury in COPD patients with pulmonary encephalopathy.